Article
A comparison of the therapeutic effectiveness of gastrin
neutralisation in two human gastric cancer models: relation to
endocrine and autocrine/paracrine gastrin mediated
growth
S A Watsona, T M Morrisa, A Varrob, D Michaelic, A M Smitha
a Academic Unit of
Cancer Studies, Department of Surgery, University of Nottingham, UK, b Department of Physiology, University of
Liverpool, UK, c Aphton
Corporation, California, USA
Correspondence to: Dr S A Watson, Academic Unit of Cancer Studies, Department of Surgery, University of Nottingham, UK.
Accepted for publication 6 July 1999
BACKGROUND
Gastrin is a growth
factor for established tumours.
AIMS
To investigate the therapeutic
effect of antibodies, raised against the Gastrimmune immunogen, which
neutralise the glycine extended and carboxy amidated forms of gastrin
17 in two human gastric cancer models.
METHODS
MGLVA1 cells (which have a
gastrin autocrine/paracrine phenotype) and ST16 cells (which have an
endocrine phenotype) were injected into the peritoneal cavity of SCID
mice. Peritoneal tumours, ascites, and cachexia formation occurred,
with the monitored endpoint being morbidity.
RESULTS
In MGLVA1 cells,
intravenous administration of antibodies raised against Gastrimmune
increased the 50% median survived by 25% at three different initial
cell seeding concentrations (1 × 106-5 × 105 per mouse). In ST16 cells, the effect of Gastrimmune
induced antibodies on time to morbidity was greatest at the lowest cell seeding concentration (5 × 105 cells/mouse) with the 50%
median survival increased by 74% and overall survival achieved in 38%
of the mice.
CONCLUSIONS
Gastrimmune may have
potential therapeutic benefit on gastrin sensitive gastric tumours and
may interact with both endocrine and autocrine mediated growth pathways.
Keywords: gastrin; gastric cancer; Gastrimmune; autocrine/paracrine growth
© 1999 by Gut
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
